Abiomed to Present at the 4th Annual Credit Suisse Small & Mid Cap Conference

Abiomed to Present at the 4th Annual Credit Suisse Small & Mid Cap Conference

DANVERS, Mass., Sept. 11, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc.
(Nasdaq:ABMD), a leading provider of breakthrough heart support technologies,
today announced that Susan V. Lisa, Senior Director, Investor Relations and
Corporate Development, will present at the 4^th Annual Credit Suisse Small &
Mid Cap Conference on Wednesday, September 18, 2013 at 2:30 p.m. ET. The
conference will be held at the Waldorf Astoria New York in New York, NY.

ABOUT ABIOMED

Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of
medical devices that provide circulatory support. Our products are designed to
enable the heart to rest by improving blood flow and/or performing the pumping
of the heart. For additional information please visit: www.abiomed.com

FORWARD-LOOKING STATEMENTS

This release contains forward-looking statements, including statements
regarding development of Abiomed's existing and new products, the Company's
progress toward commercial growth, and future opportunities and expected
regulatory approvals. The Company's actual results may differ materially from
those anticipated in these forward-looking statements based upon a number of
factors, including uncertainties associated with development, testing and
related regulatory approvals, including the potential for future losses,
complex manufacturing, high quality requirements, dependence on limited
sources of supply, competition, technological change, government regulation,
litigation matters, future capital needs and uncertainty of additional
financing, and other risks and challenges detailed in the Company's filings
with the Securities and Exchange Commission, including the most recently filed
Annual Report on Form 10-K. Readers are cautioned not to place undue reliance
on any forward-looking statements, which speak only as of the date of this
release. The Company undertakes no obligation to publicly release the results
of any revisions to these forward-looking statements that may be made to
reflect events or circumstances that occur after the date of this release or
to reflect the occurrence of unanticipated events.

CONTACT: Susie Lisa, CFA
         Senior Director, Investor Relations and Corporate Development
         978-646-1590
         slisa@abiomed.com
        
         Aimee Genzler
         Corporate Communications Manager
         978-646-1553
         ir@abiomed.com

Abiomed Logo
 
Press spacebar to pause and continue. Press esc to stop.